Hecht, M., Gostian, A. O., Eckstein, M., Rutzner, S., von der Grün, J., Illmer, T., Hautmann, M. G., Klautke, G., Laban, S., Brunner, T., Hinke, A., Becker, I., Frey, B., Semrau, S., Geppert, C. I., Hartmann, A., Balermpas, P., Budach, W., Gaipl, U. S., Iro, H., & Fietkau, R. (2020). safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8. Journal for immunotherapy of cancer, 8(2), . http://access.bl.uk/ark:/81055/vdc_100127573526.0x000032